Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 109 | 3,821 | N/A | N/A |
| TOTAL | $674 | $3,922 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 2 | 1 | N/A | N/A |
| Other Non-Current Assets | 279 | 353 | 0 | 0 |
| TOTAL | $281 | $354 | $N/A | $N/A |
| Total Assets | $955 | $4,276 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,226 | 246 | 0 | 0 |
| Accrued Expenses | 847 | 476 | N/A | N/A |
| Other current liabilities | 105 | N/A | N/A | N/A |
| TOTAL | $2,225 | $808 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 14 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 170 | 0 | 0 | 0 |
| TOTAL | $184 | $254 | $N/A | $N/A |
| Total Liabilities | $2,409 | $1,062 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -12,599 | -7,777 | N/A | N/A |
| TOTAL | $-1,454 | $3,214 | $N/A | $N/A |
| Total Liabilities And Equity | $955 | $4,276 | $0 | $0 |